| abstract |
The number of antigens that can be combined in one dosage form is limited according to the amount of each antigen necessary to elicit a desired immune response and the water solubility of the antigen, or two existing types Provision of compositions and methods that can address the challenges associated with vaccine production, such as being a mutual physical incompatibility that can be an obstacle to the simple blending of vaccines to create new combination vaccines. A first set of synthetic nanocarriers to which one or more first antigens are bound, one or more second antigens that are not bound to a synthetic nanocarrier, pharmaceutically acceptable excipients And dosage forms and related methods. [Selection figure] None |